New drugs for asthma
- 1 October 2004
- journal article
- review article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 3 (10) , 831-844
- https://doi.org/10.1038/nrd1524
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseasesNature Reviews Drug Discovery, 2003
- IL‐10 and TGF‐β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapyEuropean Journal of Immunology, 2003
- Therapeutic effects of BCG vaccination in adult asthmatic patients: a randomized, controlled trialAnnals of Allergy, Asthma & Immunology, 2002
- Cyclic nucleotide phosphodiesterasesJournal of Allergy and Clinical Immunology, 2001
- Protease-activated receptors in human airways: Upregulation of PAR-2 in respiratory epithelium from patients with asthmaJournal of Allergy and Clinical Immunology, 2001
- Effects of purine and pyrimidine nucleotides on intracellular Ca2+ in human eosinophils: Activation of purinergic P2Y receptorsJournal of Allergy and Clinical Immunology, 2001
- Biologic activities of IL-1 and its role in human diseasePublished by Elsevier ,1998
- Src family‐selective tyrosine kinase inhibitor, PP1, inhibits both FcεRI‐ and Thy‐1‐mediated activation of rat basophilic leukemia cellsEuropean Journal of Immunology, 1997
- Chloride transport and the action of sodium cromoglycate and nedocromil sodium in asthmaClinical and Experimental Allergy, 1996
- The potential role of tumour necrosis factor a in asthmaClinical and Experimental Allergy, 1993